tlsiw: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	30,487	30,405
Increase (decrease) in cash, cash equivalents and restricted cash	14,162	17,965
Cash and cash equivalents at beginning of period	8,875	-
Cash and cash equivalents at end of period	23,037	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	30,487	30,405
Increase (decrease) in cash, cash equivalents and restricted cash	14,162	17,965
Cash and cash equivalents at beginning of period	8,875	-
Cash and cash equivalents at end of period	23,037	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

TriSalus Life Sciences, Inc. (TLSIW)